PGFC
ARIA

Peapack-Gladstone Financial Corp’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-19,515
Closed -$144K – 326
2016
Q2 		$144K Sell
19,515
-2,200
-10% -$16.5K 0.01% 310
2016
Q1 		$139K Hold
21,715
– – 0.01% 310
2015
Q4 		$136K Buy
+21,715
New +$143K 0.01% 329

Other funds holding ARIA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Peapack-Gladstone Financial Corp's ARIA Position: Q3 2016 in Review

Peapack-Gladstone Financial Corp sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 19,515 shares — an estimated $144K sold.

Peapack-Gladstone Financial Corp first reported a position in ARIA in Q4 2015 and held it in 3 quarters. The position peaked at $144K in Q2 2016. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

  • Peapack-Gladstone Financial Corp reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 19,515 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $144K.
  • Peapack-Gladstone Financial Corp first reported a position in Ariad Pharmaceuticals Inc in Q4 2015 and held it in 3 quarters.
  • Peapack-Gladstone Financial Corp's Ariad Pharmaceuticals Inc position peaked at $144K in Q2 2016.
  • 202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q3 2016, filed 14 Nov 2016.